<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>GC-MS AND Chemometric Analysis of the Essential Oils Obtained from Mexican Commercial Chamomilla Recutita Teas</title>
  </titleInfo>
  <name type="personal">
    <namePart>Mata, R.</namePart>
  </name>
  <name type="personal">
    <namePart>Pérez-Vásquez, A.</namePart>
  </name>
  <name type="personal">
    <namePart>Peña-Álvarez, A.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xx</placeTerm>
    </place>
    <dateIssued encoding="marc">9999</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">und</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
  </physicalDescription>
  <abstract>The essential oils prepared by hydrodistillation of twenty-one brands of German chamomile (S1-S21)commercialized in Mexico were analyzed by GS-MS. Altogether, twenty-four different compounds were identified in the analyzed samples, varying from 77 to 100 percent of the total composition. Multivariate analyses were applied to explore similarity/dissimilarity and correlation between all samples; the results revealed a strong correlation among samples S4, S5, and S7-S21 due to the presence of (Z)-en-yn-dicycloether [(Z)-tonghaosu], ?-bisabolol, ?-farnesene, ?-eudesmol, and xanthoxylin. The samples S1-S3 and S6 were clustered separately. Samples S1, S3, and S6 were characterized by their higher content of bisabolol oxide A (38.78 percent, 51.84 percent, and 70.46 percent, respectively)as most known chemotypes of German chamomile, but only S1 and S3 contained chamazulene. Finally, S2 differed from the others because of its high content of (E)-anethole (62.28 percent), suggesting a case of adulteration or substitution of the crude drug employed for manufacturing the product.</abstract>
  <subject>
    <topic>GC-MS</topic>
  </subject>
  <subject>
    <topic>MATRICARIA RECUTITA</topic>
  </subject>
  <subject>
    <topic>MANZANILLA</topic>
  </subject>
  <subject>
    <topic>MULTIVARIATE ANALYSIS</topic>
  </subject>
  <relatedItem type="series">
    <titleInfo>
      <title>Chemistry &amp; BioDiversity, 19, p.e202400333, 2024</title>
    </titleInfo>
  </relatedItem>
  <identifier type="uri">https://drive.google.com/open?id=1Zxcjib45pYkjWKvA83_Jxv38ZdfSfCOz&amp;usp=drive_copy</identifier>
  <location>
    <url>https://drive.google.com/open?id=1Zxcjib45pYkjWKvA83_Jxv38ZdfSfCOz&amp;usp=drive_copy</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg"/>
    <recordCreationDate encoding="marc">250602</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260521091753.0</recordChangeDate>
  </recordInfo>
</mods>
